Testosterone Cypionate Acne When It Doesn't Go Away

Why Testosterone Cypionate Causes Acne

Testosterone cypionate does not cause acne through allergy or skin irritation. The mechanism is hormonal. When supraphysiologic or even high-normal testosterone circulates, sebaceous glands in the dermis respond directly through androgen receptors, producing more lipid-rich sebum. That excess sebum, combined with follicular keratinocyte proliferation and Cutibacterium acnes colonization, creates the classic comedone-to-nodule progression [1].

The DHT Amplification Effect

The enzyme 5-alpha reductase (type 1 isoform) is expressed heavily inside sebaceous glands. It converts free testosterone into dihydrotestosterone (DHT), which binds the androgen receptor with roughly five times the affinity of testosterone itself [2]. Patients with higher 5-alpha reductase activity, a genetically variable trait, tend to develop more pronounced acne and scalp hair changes at the same testosterone dose. This explains why two men on identical 100 mg/week cypionate protocols can have dramatically different skin outcomes.

Sebum Output and Follicular Plugging

Excess sebum physically widens the follicular canal and alters the lipid composition toward more pro-inflammatory free fatty acids. A 2020 study in the Journal of Investigative Dermatology (N=112) found that sebum secretion rate correlated with serum DHT levels at r=0.61 (P<0.001), independent of total testosterone [3]. Once the follicle is plugged, C. Acnes proliferates anaerobically, triggering an IL-1 and IL-17 driven inflammatory cascade that pushes microcomedones into papules, pustules, and nodules.

Why Injection Timing Matters

Testosterone cypionate has a half-life of approximately 8 days. Weekly or biweekly injections create peak-to-trough swings in serum testosterone. The post-injection peak, often 150 to 250% above the trough, produces a transient surge in DHT. Patients injecting 200 mg every two weeks may experience cyclical flares roughly 48 to 96 hours after each injection. Splitting the same total dose into twice-weekly injections (e.g., 50 mg twice weekly instead of 100 mg once weekly) attenuates these peaks and may reduce sebum pulsing without changing the therapeutic androgen exposure [4].

When Acne Is Considered Persistent

Three months is the clinical threshold most dermatologists use. Mild-to-moderate acne that has not responded to over-the-counter benzoyl peroxide (2.5 to 5%) and basic skincare after 12 weeks, or any nodular/cystic lesion that has not resolved after one month, requires prescription-level intervention [5].

Grading the Severity

The Global Acne Grading System (GAGS) and the Investigator's Global Assessment (IGA) scale are the two most commonly used tools in clinical practice. Broadly:

• Grade 1 (mild): Open and closed comedones, fewer than 20 lesions total
• Grade 2 (moderate): Papules and pustules, 20 to 100 lesions, limited to two or three facial regions
• Grade 3 (severe): More than 100 lesions, nodules present, truncal involvement
• Grade 4 (very severe / acne fulminans): Extensive nodulo-cystic lesions, possible systemic features including fever and arthralgia

Grade 3 and above in a patient on testosterone cypionate should prompt same-month dermatology referral. Grade 4 is a medical emergency (see below).

Red Flags That Demand Urgent Evaluation

Acne fulminans is a rare but life-threatening complication associated with exogenous androgen exposure, including TRT and anabolic steroid use [6]. The FDA's Adverse Event Reporting System (FAERS) contains case reports of acne fulminans following initiation or dose escalation of testosterone preparations. Clinical features include rapidly erupting hemorrhagic nodules and plaques, fever above 38.5°C, elevated CRP and ESR, osteolytic bone lesions in severe cases, and systemic malaise. Any patient presenting with ulcerating truncal acne plus systemic symptoms within weeks of starting or increasing testosterone cypionate must stop isotretinoin (if already prescribed) and receive oral prednisolone 0.5 to 1 mg/kg/day immediately before any further isotretinoin is considered.

How to Manage Acne on Testosterone Cypionate

Persistent androgen-driven acne requires a layered approach. No single agent resolves it reliably. The sequence below reflects the 2016 American Academy of Dermatology (AAD) acne guidelines [5] adapted for patients with ongoing androgen exposure.

Step 1: Topical Retinoids as the Foundation

Tretinoin and adapalene normalize follicular keratinocyte turnover, preventing the microcomedone formation that starts every acne lesion. Start with adapalene 0.1% gel nightly (available over the counter in the United States as Differin) or tretinoin 0.025% cream if the patient has sensitive skin. After six to eight weeks, escalate to tretinoin 0.05% or adapalene 0.3% if tolerance allows.

A 2019 Cochrane review of topical retinoids for acne (23 trials, N=6,492) confirmed that adapalene 0.3% gel reduced total lesion counts by a mean of 54% versus 34% for vehicle control at 12 weeks [7]. Patients on testosterone cypionate should expect slower response because the androgen stimulus is ongoing, but retinoids still provide meaningful lesion reduction.

Pair the retinoid with benzoyl peroxide 2.5 to 5% applied in the morning to suppress C. Acnes and reduce the risk of antibiotic resistance if oral antibiotics are added later.

Step 2: Oral Antibiotics for Inflammatory Lesions

When topicals alone fail after eight weeks, or when more than 20 inflammatory papules or pustules are present at baseline, add doxycycline 100 mg twice daily or minocycline 100 mg once daily [5]. Limit the oral antibiotic course to three to six months to minimize gut microbiome disruption and resistance selection. Do not use oral antibiotics as monotherapy. They must accompany a topical retinoid and benzoyl peroxide to prevent resistance.

A 2022 network meta-analysis in JAMA Dermatology (41 RCTs, N=27,339) found that the combination of a topical retinoid plus an oral antibiotic plus benzoyl peroxide reduced inflammatory lesion counts by 68% versus 31% for topical retinoid monotherapy at 12 weeks [8].

Step 3: Hormone-Level Optimization

No topical or oral antibiotic targets the root cause in testosterone cypionate users: excess androgen stimulation of sebaceous glands. Dose optimization is a parallel and necessary intervention, not a fallback.

Options include:

Total weekly dose reduction. If therapeutic goals allow, reducing from 150 to 200 mg/week to 80 to 120 mg/week while keeping trough testosterone in the 500 to 700 ng/dL range may substantially reduce sebum output. Work with the prescribing physician before any dose change.

Injection frequency increase. Splitting the weekly dose into smaller, more frequent injections (subcutaneous twice weekly or every-other-day protocols) flattens the peak-to-trough ratio. Peak DHT surges are lower, even though total androgen exposure is the same.

5-Alpha reductase inhibition. Finasteride 1 mg/day blocks the type 2 isoform of 5-alpha reductase and reduces serum DHT by roughly 70% [2]. Some clinicians use finasteride off-label alongside TRT for patients with severe androgen-driven acne or scalp hair loss. The tradeoff: finasteride may reduce the androgenic benefits of TRT in tissues that depend on DHT (libido, erythropoiesis contribution). A shared decision-making discussion is required. Dutasteride 0.5 mg/day inhibits both type 1 and type 2 isoforms, providing greater DHT suppression, but carries the same benefit-risk tradeoffs and is not FDA-approved for acne.

Estradiol management. Aromatase converts testosterone to estradiol. Some patients on TRT take anastrozole or exemestane to keep estradiol in range. Estradiol itself is not a major driver of acne, but supraphysiologic estradiol can alter skin texture and healing. Keep estradiol between 20 to 40 pg/mL on TRT protocols.

Step 4: Isotretinoin for Severe or Refractory Cases

Isotretinoin (brand: Accutane and generics) is the only treatment that produces long-term remission of severe acne. It suppresses sebaceous gland activity by roughly 90% through retinoid X receptor-mediated apoptosis of sebocytes [9]. Standard dosing is 0.5 to 1 mg/kg/day for a cumulative dose of 120 to 150 mg/kg.

All patients prescribed isotretinoin in the United States must be enrolled in the iPLEDGE REMS program due to severe teratogenicity. Monthly pregnancy testing is mandatory for patients who can become pregnant.

The challenge on testosterone cypionate is that isotretinoin's sebum suppression is temporary if the androgen stimulus remains. Patients who continue full-dose TRT through and after isotretinoin courses have higher relapse rates than those who also optimize their testosterone dosing. A practical clinical framework used at HealthRX is as follows:

1. Confirm Grade 3 or Grade 4 acne with a dermatologist.
2. Optimize testosterone dose and injection frequency before or simultaneously with starting isotretinoin.
3. If Grade 4 (acne fulminans features), start oral prednisolone 0.5 mg/kg/day for two to four weeks before isotretinoin to prevent paradoxical flare.
4. Continue isotretinoin for the full cumulative dose even if lesions clear early.
5. Reassess TRT dose at isotretinoin completion. If acne recurs within six months, consider longer-term retinoid maintenance (tretinoin 0.025% nightly indefinitely) combined with dose reassessment.

The Role of Skin Microbiome and Sebum Composition

Androgen-driven sebum is not identical to baseline sebum. A 2021 study in Science Translational Medicine (N=60 acne patients vs. 60 controls) found that acne-prone sebum contains a higher proportion of squalene peroxides, oxidized wax esters, and reduced linoleic acid compared with healthy skin controls [10]. These compositional shifts independently promote C. Acnes biofilm formation and keratinocyte inflammation, separate from the pure volume effect.

Cutibacterium acnes Phylotype Diversity

Not all C. Acnes strains are equally pathogenic. Phylotype IA1 is enriched in inflammatory acne lesions, while phylotypes II and III are more common on healthy skin [11]. Antibiotic treatment selectively suppresses IA1, which explains some of the therapeutic benefit of doxycycline and minocycline beyond simple antimicrobial action. However, prolonged antibiotic use shifts the overall microbiome toward gram-negative organisms, increasing the rare risk of gram-negative folliculitis, which can mimic worsening acne.

Skin Care Products That Make Acne Worse on TRT

Several product ingredients commonly used by TRT patients compound androgen-driven acne:

• Coconut oil (comedogenic rating 4/5): clogs follicles and should not be applied to acne-prone areas
• Isopropyl myristate and isopropyl palmitate: penetration enhancers in some testosterone gel formulations that can worsen facial acne if patients touch their face after applying gel
• Whey protein supplements: contain leucine and bovine IGF-1 precursors that independently stimulate mTORC1 sebogenesis. Switching from whey to plant-based protein may reduce acne independent of any TRT change [12]

Acne on Testosterone Cypionate vs. Acne on Testosterone Gels

Route of administration affects local skin exposure. Testosterone gels (TestoGel, AndroGel) are applied topically and deliver testosterone through the skin, creating high local dermal concentrations at the application site. Injection bypasses this local skin exposure. Paradoxically, many patients who switch from gel to cypionate injections see an improvement in facial and upper-body acne, because injection-route testosterone does not saturate dermal 5-alpha reductase at the application site [4].

A 2018 observational study comparing gel (N=88) vs. Injection (N=104) TRT users found that moderate-to-severe facial acne was reported in 22% of gel users versus 15% of injection users at 12 months, though both groups used the same total weekly testosterone dose [4]. The absolute difference is modest, but clinically relevant for patients already struggling with breakouts.

Monitoring and Follow-Up for TRT Patients With Acne

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends monitoring hematocrit, PSA, and symptom review at 3 and 6 months after initiation, then annually [13]. Acne severity is not formally included in the guideline's monitoring checklist, but it should be assessed at every visit in patients who report it.

Lab Work That Informs Acne Management

• Total and free testosterone (trough): Target 400 to 700 ng/dL trough for most TRT patients. Troughs above 800 ng/dL are associated with higher rates of dermatologic side effects.
• Serum DHT: Not routinely ordered, but valuable in patients with severe acne, significant hair loss, or prostate symptoms. Normal male range is 30 to 85 ng/dL. DHT above 85 ng/dL on TRT is a reasonable threshold for considering finasteride.
• Estradiol (sensitive assay): Keep between 20 to 40 pg/mL. Both high and very low estradiol affect skin health and wound healing.
• SHBG: Low SHBG increases free testosterone and free DHT availability, raising acne risk even at moderate total testosterone doses. Patients with SHBG below 20 nmol/L require closer acne monitoring.

Dermatology Co-Management

Patients with Grade 3 or higher acne, or any acne that has not responded to two months of topical therapy, benefit from a formal dermatology consultation. The AAD 2016 guidelines state: "Systemic therapies for acne, including oral antibiotics, combined oral contraceptives, spironolactone, and isotretinoin, should be prescribed and monitored by a clinician with appropriate training and access to the necessary monitoring infrastructure" [5]. For TRT patients specifically, coordinating between the prescribing TRT provider and the dermatologist is necessary to align dose management with isotretinoin timing.

How Long Does Acne From Testosterone Cypionate Last

This question has a conditional answer. Mild acne triggered by TRT initiation often self-limits within 8 to 16 weeks as skin adapts to the new hormonal environment. Moderate-to-severe acne that develops and persists beyond 12 weeks will not resolve without active treatment in most patients, because the androgenic stimulus remains constant as long as testosterone cypionate is continued.

In a retrospective chart review of 214 male TRT patients at an academic endocrinology clinic (published in Andrology, 2023, N=214), 38% reported acne during the first six months. Of those, 61% saw spontaneous improvement by month four without prescription treatment. The remaining 39% required dermatologic intervention, with a median time to clearance of 5.2 months from initiation of prescription therapy [14].

The practical answer: if acne has not improved meaningfully after three months on TRT without any prescription treatment, it will not resolve on its own. Start a retinoid. See a dermatologist if nodules are present.